KR20050106631A - Mineral health drink containing germanium and selenium - Google Patents
Mineral health drink containing germanium and selenium Download PDFInfo
- Publication number
- KR20050106631A KR20050106631A KR1020040031621A KR20040031621A KR20050106631A KR 20050106631 A KR20050106631 A KR 20050106631A KR 1020040031621 A KR1020040031621 A KR 1020040031621A KR 20040031621 A KR20040031621 A KR 20040031621A KR 20050106631 A KR20050106631 A KR 20050106631A
- Authority
- KR
- South Korea
- Prior art keywords
- mushroom
- selenium
- germanium
- extract
- weight
- Prior art date
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 36
- 239000011707 mineral Substances 0.000 title claims abstract description 36
- 239000011669 selenium Substances 0.000 title claims abstract description 26
- 229910052732 germanium Inorganic materials 0.000 title claims abstract description 24
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 title claims abstract description 24
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 23
- 230000036541 health Effects 0.000 title claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 32
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 22
- 235000013361 beverage Nutrition 0.000 claims abstract description 20
- 239000011575 calcium Substances 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 14
- 229930003231 vitamin Natural products 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 13
- 229940088594 vitamin Drugs 0.000 claims abstract description 13
- 239000011777 magnesium Substances 0.000 claims abstract description 11
- 239000011734 sodium Substances 0.000 claims abstract description 11
- 229910052742 iron Inorganic materials 0.000 claims abstract description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000012676 herbal extract Substances 0.000 claims abstract description 9
- 239000011591 potassium Substances 0.000 claims abstract description 9
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 8
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims abstract description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000000654 additive Substances 0.000 claims abstract description 6
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000011737 fluorine Substances 0.000 claims abstract description 6
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 6
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 6
- 239000010703 silicon Substances 0.000 claims abstract description 6
- 239000011701 zinc Substances 0.000 claims abstract description 6
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- 241000411851 herbal medicine Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims description 5
- 240000004371 Panax ginseng Species 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 4
- 229940010454 licorice Drugs 0.000 claims description 4
- 241000222518 Agaricus Species 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims description 3
- 240000002045 Guettarda speciosa Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- 235000015468 Lycium chinense Nutrition 0.000 claims description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 3
- 240000006079 Schisandra chinensis Species 0.000 claims description 3
- 241000121220 Tricholoma matsutake Species 0.000 claims description 3
- 235000006533 astragalus Nutrition 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 210000004233 talus Anatomy 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 2
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 244000144730 Amygdalus persica Species 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 241000167854 Bourreria succulenta Species 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 241000220225 Malus Species 0.000 claims description 2
- 235000011430 Malus pumila Nutrition 0.000 claims description 2
- 235000015103 Malus silvestris Nutrition 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- 244000025272 Persea americana Species 0.000 claims description 2
- 235000008673 Persea americana Nutrition 0.000 claims description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 2
- 244000294611 Punica granatum Species 0.000 claims description 2
- 235000014360 Punica granatum Nutrition 0.000 claims description 2
- 235000014443 Pyrus communis Nutrition 0.000 claims description 2
- 240000001987 Pyrus communis Species 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 235000019693 cherries Nutrition 0.000 claims description 2
- 235000003599 food sweetener Nutrition 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000003765 sweetening agent Substances 0.000 claims description 2
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 9
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 201000011510 cancer Diseases 0.000 abstract description 5
- 239000013589 supplement Substances 0.000 abstract description 3
- 235000010755 mineral Nutrition 0.000 description 28
- 230000000694 effects Effects 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 230000001093 anti-cancer Effects 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 8
- 230000003204 osmotic effect Effects 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 230000002354 daily effect Effects 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 208000007502 anemia Diseases 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 235000012206 bottled water Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 238000002441 X-ray diffraction Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 208000007442 rickets Diseases 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 235000020679 tap water Nutrition 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 208000028017 Psychotic disease Diseases 0.000 description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000021321 essential mineral Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 208000005368 osteomalacia Diseases 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000004203 pancreatic function Effects 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 206010038038 rectal cancer Diseases 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical group ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WXLQTJWFQSFIGM-UHFFFAOYSA-N 2,2-dibromo-1-chloropropane Chemical compound CC(Br)(Br)CCl WXLQTJWFQSFIGM-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003805 Autism Diseases 0.000 description 1
- 208000020706 Autistic disease Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009208 Cirrhosis alcoholic Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010254 Concussion Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061825 Duodenal neoplasm Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229910005793 GeO 2 Inorganic materials 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010027951 Mood swings Diseases 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 229910003251 Na K Inorganic materials 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000013612 Parathyroid disease Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- UFCGDBKFOKKVAC-DSASHONVSA-N Schisantherin A Chemical compound O([C@H]1C=2C=C(C(=C(OC)C=2C2=C(OC)C=3OCOC=3C=C2C[C@H](C)[C@@]1(O)C)OC)OC)C(=O)C1=CC=CC=C1 UFCGDBKFOKKVAC-DSASHONVSA-N 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010054184 Small intestine carcinoma Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 229910009378 Zn Ca Inorganic materials 0.000 description 1
- MGFAJHVKMKDQIT-UHFFFAOYSA-N [C].[C].[C].[C].[C] Chemical compound [C].[C].[C].[C].[C] MGFAJHVKMKDQIT-UHFFFAOYSA-N 0.000 description 1
- MMDJDBSEMBIJBB-UHFFFAOYSA-N [O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[NH6+3] Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[NH6+3] MMDJDBSEMBIJBB-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 208000010002 alcoholic liver cirrhosis Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- JOPOVCBBYLSVDA-UHFFFAOYSA-N chromium(6+) Chemical compound [Cr+6] JOPOVCBBYLSVDA-UHFFFAOYSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- -1 circulatory system Substances 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 235000021403 cultural food Nutrition 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000000312 duodenum cancer Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 150000002291 germanium compounds Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229930186755 gomisin Natural products 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 231100000849 liver cell damage Toxicity 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003129 oil well Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000001337 psychedelic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/702—Vitamin A
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7042—Vitamin B1
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7044—Vitamin B2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/7052—Vitamin B6
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/704—Vitamin B
- A23V2250/706—Vitamin B12
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/708—Vitamin C
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/71—Vitamin D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/71—Vitamin D
- A23V2250/7104—Vitamin D2
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/71—Vitamin D
- A23V2250/7106—Vitamin D3
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 게르마늄 및 셀레늄 함유 미네랄 건강 음료수에 관한 것으로, 게르마늄 0.05-0.1ppm, 셀레늄 0.01-0.04ppm, 불소 0.1-1.3ppm, 철 0.005-0.02ppm, 아연 0.005-0.02ppm, 칼슘 20-40ppm, 마그네슘 5-15ppm, 나트륨 0.1-1.5ppm, 칼륨 0.1-1ppm, 실리콘 0.1-1ppm 및 알루미늄 0.01-0.2ppm을 함유하는 광천수 30-70중량%, 한약재 추출물 14-30중량%, 버섯추출물 14-30중량%, 비타민류 1-5중량% 및 기타 첨가제 1-5중량%를 포함하여 이루어진 게르마늄 및 셀레늄 함유 미네랄 건강 음료수가 제공된다.The present invention relates to germanium and selenium-containing mineral health beverages, germanium 0.05-0.1ppm, selenium 0.01-0.04ppm, fluorine 0.1-1.3ppm, iron 0.005-0.02ppm, zinc 0.005-0.02ppm, calcium 20-40ppm, magnesium 5-15ppm, 0.1-1.5ppm sodium, 0.1-1ppm potassium, 0.1-1ppm silicon and 0.01-0.2ppm aluminum, 30-70% by weight mineral water, 14-30% herbal extract, 14-30% mushroom extract A germanium and selenium-containing mineral health beverage comprising 1-5% by weight of vitamins and 1-5% by weight of other additives is provided.
본 발명의 건강 음료수는 인체에 필요한 게르마늄과 셀레늄을 포함한 각종 미네랄 성분을 보충시켜줄 수 있으며 또한 추가적으로 몸에 유익한 한약재추출물, 버섯추출물, 비타민 등이 함유되어 있어 암예방 및 성인병 예방에도 도움이 되는 등 건강 증진 효과를 기대할 수 있다. The health drink of the present invention can supplement various mineral components including germanium and selenium necessary for the human body, and also contain beneficial herbal extracts, mushroom extracts, vitamins, etc., which are beneficial to the body, and thus help prevent cancer and prevent adult diseases. You can expect a boost.
Description
본 발명은 미네랄 함유 건강 음료수에 관한 것으로, 특히 게르마늄과 셀레늄이 함유된 광천수를 포함하는 건강 음료수에 관한 것이다.The present invention relates to mineral-containing healthy beverages, and more particularly, to healthy beverages containing mineral water containing germanium and selenium.
상업적으로 판매되고 있는 음료수는 일반적으로 갈증을 해소하거나 맛을 즐기기 위한 것으로 생수, 청량음료, 주류, 과실음료, 커피 등이 있다. 이러한 음료들은 주로 탄산가스를 함유시켜 보다 시원하고 자극적인 맛을 내거나 카페인, 향료, 색소 등을 첨가시켜 맛을 좋게한 것이 대부분이다. Commercially sold beverages are generally for quenching thirst or to enjoy taste, and include bottled water, soft drinks, alcoholic beverages, fruit drinks, and coffee. Most of these drinks contain carbon dioxide, which gives a cooler, more irritating taste, or the addition of caffeine, fragrances, colorants, etc., to improve taste.
그러나, 이러한 기존의 음료들은 단순히 수분과 전해질을 보충한다는 점 외에는 인체에 유익한 특성을 갖지 못하고 있다. 특히, 현대인의 음료들은 보다 자극적인 맛을 내기위해 중독성이 강한 카페인을 첨가시킴에 따라 오히려 소비자의 건강을 해칠 뿐만 아니라 당도가 매우 높아 유소년들의 치아를 상하게 하는 등 건강을 저하시키는 원인이 되기도 한다.However, these conventional beverages do not have beneficial properties for the human body other than simply replenishing water and electrolytes. In particular, modern beverages add addictive caffeine for a more stimulating taste, which not only hurts the health of consumers, but also causes the health of children to be deteriorated, such as damaging the teeth of children.
그래서 이에 부응하여 각종 미네랄, 생약재나 한약재 추출물이 첨가된 한방음료나 기능성 음료가 많이 개발되었으나 아직까지 그 효능이 확실하게 입증된 바는 없다. So, in response to this, a lot of herbal drinks or functional drinks to which various minerals, herbal medicines or herbal extracts have been added have been developed, but their efficacy has not been proven yet.
인체는 영양의 3대 요소인 단백질, 전분질, 지질과 비타민 등의 기본 영양을 필요로 하지만 나트륨, 칼슘, 마그네슘, 칼륨, 셀레늄, 게르마늄 등의 미네랄도 필요로 하는 것으로 알려져 있다. 또한 근래의 음식문화는 고단백에 비타민을 첨가한 음식이 발달해 있으므로 이러한 미네랄이 결핍될 확률이 높으며, 미네랄이 결핍될 경우 여러가지 결핍증상이 발생할 수 있다. The human body needs basic nutrition such as protein, starch, lipids and vitamins, which are the three major elements of nutrition, but it is also known to require minerals such as sodium, calcium, magnesium, potassium, selenium and germanium. In addition, the recent food culture is a high protein foods with vitamins are developed, so there is a high probability of deficiency of these minerals, if the deficiency of minerals may cause various deficiency symptoms.
필수적인 미네랄의 결핍증과 효능을 살펴보면, 먼저 구리(Cu)는 체내에서 효소를 비롯한 여러 단백질의 한 부분으로서 존재하는 필수적인 미량원소로서, 저장된 철분과 장관내의 철분을 헤모글로빈 생성 장소로 운반하는 역할을 하고, 또한 미토콘드리아내 전자전달계의 마지막 과정에 작용하여 ATP(adenosine triphosphate) 생성에 관여하고, 또한 골격성과 심장순환계의 결합조직을 정상으로 유지하는 데에도 기여하고, 단독 또는 아연과 함께 항산화효소인 SOD(Superoxide Dismutase)에 결합되어 세포의 산화적 손상을 방지하는 역할도 한다. 결핍시에는 빈혈, 백혈구 감소, 호중구 감소가 일어나게 되며, 효능으로는 심장혈관질환 예방, 관절염 치료, 산화방지 기능 및 항염증 효과를 볼 수 있으며, 일일 권장량은 1.5 내지 3.0㎎/일이다.In view of the deficiency and efficacy of essential minerals, first, Cu is an essential trace element present in the body as part of enzymes and other proteins, which transports stored iron and intestinal iron to hemoglobin production sites. In addition, it is involved in the production of ATP (adenosine triphosphate) by acting in the final process of electron transport system in the mitochondria, and also contributes to maintaining the connective tissues of skeletal and cardiac circulation normal, and the antioxidant enzyme SOD (Superoxide) alone or in combination with zinc. Dismutase) also prevents oxidative damage to cells. In deficiency, anemia, leukocyte reduction, and neutrophil reduction occur, and as an effect, cardiovascular disease prevention, arthritis treatment, antioxidant function, and anti-inflammatory effect can be seen, and the daily recommended amount is 1.5 to 3.0 mg / day.
나트륨(Na)는 세포외액의 중요한 성분으로서, 염소이온과 중탄산이온과 함께 인체의 산염기평형을 유지하고, 체액의 삼투압유지 및 체액량을 결정하는데 중요한 역할을 하며, 결핍시에는 심신이 허약하고 근육경련, 체중감소, 두통 및 불면을 유발되며, 효능으로는 정상 체액유지와 공급, 인체의 정상적인 산염기 균형유지, 정상적인 근육반응 유지 또는 정상적인 삼투압 유지 효과를 볼 수 있고, 1일 권장량은 10g 이하이나 한국인은 보통 10 내지 30g을 섭취한다.Sodium (Na) is an important component of extracellular fluid, along with chlorine and bicarbonate ions, plays an important role in maintaining the acid-base equilibrium of the body, maintaining the osmotic pressure of body fluids, and determining the amount of fluid. It can cause cramps, weight loss, headaches, and insomnia.Its effects include maintaining and supplying normal fluids, maintaining the normal acid balance of the human body, maintaining normal muscle reactions, or maintaining normal osmotic pressure. Koreans usually consume 10 to 30 grams.
마그네슘(Mg)은 인체내에 약 20 내지 28g이 존재하며, 약 60%가 뼈, 26%는 근육, 나머지는 연조직과 체액에 있으며, 세포내액의 중요한 구성성분으로서, 결핍시에는 신장 결석같은 신장 질환, 갑상선 기능항진증, 급성 알콜중독, 부갑상선장애, 근육경련 등이 유발되며, 효능으로는 당질대사, 지질대사, 단백질 대사와 핵산의 합성분해, 체내의 인지질(레시틴)의 합성을 돕고, 비타민 C, B 복합체, 인, 나트륨, 칼륨 및 칼슘의 대사를 보조하고 신경계통의 흥분 진정 효과를 볼 수 있으며, 1일 권장량은 300㎎이다.Magnesium (Mg) is present in the body of about 20 to 28g, about 60% in bone, 26% in muscle, the rest in soft tissues and body fluids, an important component of intracellular fluid, kidney disease, such as kidney stones when deficient , Hyperthyroidism, acute alcoholism, parathyroid disorders, muscle cramps, etc., and the effects include carbohydrate metabolism, lipid metabolism, protein metabolism and synthesis of nucleic acids, help the synthesis of phospholipids (lecithin) in the body, vitamin C, It can assist with metabolism of B complex, phosphorus, sodium, potassium and calcium, and stimulate the nervous system's excitement, and the recommended daily amount is 300mg.
망간(Mn)은 여러 가지 효소의 활성화작용에 기여하며, 결핍시에는 체중감소, 피부염, 오심 또는 구토, 머리칼 변색, 생식능력 저하 또는 췌장기능 저하로 인한 당뇨 증상이 유발되며, 효능으로는 노이로제, 조울증 또는 정신분열증 등과 같은 정신병적 증상의 치료 효과, 성적 능력 강화, 당뇨 및 천식 치료 효과를 볼 수 있고, 1일 권장량은 2.5 내지 5㎎이다.Manganese (Mn) contributes to the activation of various enzymes, and deficiency causes diabetes symptoms due to weight loss, dermatitis, nausea or vomiting, discoloration of hair, decreased fertility or reduced pancreatic function. The treatment effect of psychotic symptoms such as mood swings or schizophrenia, sexual enhancement, diabetes and asthma treatment effect can be seen, the daily recommended amount is 2.5 to 5 mg.
셀레늄(Se)은 천연토코페롤의 1,970배에 이르는 항산화력을 가지고 있으며, 결핍시에는 암, 심장질환, 면역기능 저하, 적혈구 기능저하, 근육통, 심근 퇴하, 근긴장 증강, 췌장기능 퇴하 등이 유발되며, 효능으로는 중금속의 무독화, 항산화작용, 항노화, 항암, 심장혈관질환 예방, 간경화 예방, 염증성 질환 예방, 당뇨병 합병증 예방, 간장 및 신장의 기능 강화, 생식기능 강화, 백내장 예방, 면역기능 향상 등의 효과를 볼 수 있고, 1일 권장량은 50 내지 200㎍이다.Selenium (Se) has 1,970 times the antioxidant power of natural tocopherol, and deficiency causes cancer, heart disease, decreased immune function, red blood cell function, muscle pain, myocardial decline, muscle tone enhancement, and pancreatic function decline. Benefits include detoxification of heavy metals, antioxidant activity, anti-aging, anti-cancer, prevention of cardiovascular disease, prevention of liver cirrhosis, prevention of inflammatory diseases, prevention of complications of diabetes, enhancement of liver and kidney function, enhancement of reproductive function, prevention of cataracts, improvement of immune function, etc. The effect of can be seen, the recommended daily amount is 50 to 200 μg.
아연(Zn)은 모든 체세포안에 있으며, 200개가 넘는 효소들의 구성성분으로서, 결핍시에는 태아의 기형발생 유발, 수면 및 행동 장애, 여드름 또는 피부염 발생, 알콜성 간경화, 염증성 장질환, 자폐증 또는 정신병 등이 유발되며, 효능으로는 태아 성장 촉진, 정자 형성 촉진, 피부 저항력 강화 및 피부염 치료, 성장발육 촉진, 인슐린 분비 증강, 동맥경화 예방 또는 갑상선 기능 조절 등의 효과를 볼 수 있고, 1일 권장량은 15㎎이다. Zinc (Zn) is found in all somatic cells and is a constituent of more than 200 enzymes that, when deficient, cause fetal malformations, sleep and behavioral disorders, acne or dermatitis, alcoholic cirrhosis, inflammatory bowel disease, autism or psychosis. It is induced, and it can be effective in promoting fetal growth, promoting sperm formation, strengthening skin resistance and treating dermatitis, promoting growth and development, enhancing insulin secretion, preventing atherosclerosis, or controlling thyroid function. Mg.
인(P)은 칼슘 다음으로 체내에 많은 무기질로 인체의 전체 미네랄 중 22%를 차지하며, 에너지의 저장과 방출에 관여하고 인지질과 리포단백의 구성성분이며 세포의 구조와 기능에 중요한 역할을 하고, 핵산의 보조효소로도 작용한다. 결핍시에는 ATP 합성저하로 무기력해지며, 유아의 체중감소, 구루병, 성인의 골연화증이 유발되며, 효능으로는 칼슘과 결합하여 구루병과 골연화증을 예방하고 많은 비타민 B와 결합하여 효소활성을 가지며, 1일 권장량은 800㎎이다.Phosphorus (P) is the second largest mineral in the body after calcium. It is responsible for 22% of the total minerals in the human body. It is involved in the storage and release of energy, is a component of phospholipids and lipoproteins, and plays an important role in the structure and function of cells. It also acts as a coenzyme for nucleic acids. In case of deficiency, it becomes lethargic due to a decrease in ATP synthesis, induces weight loss in children, rickets disease, osteomalacia in adults, and as an effect, combines with calcium to prevent rickets and osteomalacia, and combines with many vitamin B to have enzymatic activity, 1 The recommended daily dose is 800 mg.
칼륨(K)은 성인의 체내총량이 150g정도로 세포내액의 산·알칼리 평형에 가장 중요한 미네랄이며, 결핍시에는 부정맥, 저혈당, 무력증 등이 유발되며, 효능으로는 정상 체액유지와 공급, 인체의 정상적인 산염기 균형유지, 정상적인 근육반응 유지, 정상적인 삼투압유지, 혈관 확장, 인슐린 분비 촉진, 심근경색의 방어효과를 볼 수 있고, 1일 권장량은 3,600 내지 10,000mg이다.Potassium (K) is the most important mineral for acid and alkali equilibrium of intracellular fluid with the total body weight of adult is about 150g, and deficiency causes arrhythmia, hypoglycemia, asthenia, etc. Acidic balance, maintaining normal muscle reactions, maintaining normal osmotic pressure, vasodilation, promoting insulin secretion, the defense effect of myocardial infarction, the recommended daily dose is 3600 to 10,000mg.
칼슘(Ca)은 체내 무기질 중 가장 양이 많은 원소로, 매일 700mg 정도의 칼슘이 뼈와 혈액사이를 이동한다. 결핍시에는 혈액속의 칼슘저하로 말초신경과 근육접합부의 흥분성이 높아져 가벼운 자극으로 근육, 주로 손·발·안면 근육이 수축 및 경련을 일으키는 테타니증이 유발되며, 효능으로는 골다공증, 구루병, 골절, 충치, 퇴행변성 관절증의 치료효과, 고혈압, 동맥경화증, 설사 또는 당뇨의 예방, 알레르기 질환 또는 감기 예방, 불면증, 신경과민의 치료, 심근 수축력의 증강, 신경 및 근육의 흥분, 혈액응고작용의 촉진 효과를 볼 수 있고, 1일 권장량은 1 내지 1.2g이다.Calcium (Ca) is the most abundant element in the body's minerals, about 700 mg of calcium between the bones and the blood every day. The deficiency increases the excitability of peripheral nerves and muscle junctions due to a decrease in calcium in the blood, causing mild stimulation of tetanosis, which causes muscles, mainly the hands, feet, and facial muscles to contract and cramp.The effects include osteoporosis, rickets, fractures, Treatment of tooth decay, degenerative arthrosis, prevention of hypertension, arteriosclerosis, diarrhea or diabetes, prevention of allergic diseases or colds, insomnia, nerve hypersensitivity, strengthening myocardial contractility, excitement of nerves and muscles, promoting blood coagulation It can be seen, the recommended daily amount is 1 to 1.2g.
철(Fe)은 헤모글로빈 속에 함유되어 산소와 결합하는 데 중요한 역할을 하는데, 철분이 부족하면 헤모글로빈을 생성할 수 없어서 적혈구도 보통보다 작아지게 되며 안색이 나빠지고, 쉽게 피로해지며 철분의 균형을 잃게 되어 빈혈이 유발된다. Iron (Fe) is contained in hemoglobin and plays an important role in binding to oxygen. When iron is insufficient, hemoglobin cannot produce hemoglobin, causing red blood cells to become smaller than normal, making the complexion worse, fatigue, and unbalanced iron. Anemia is caused.
따라서, 이러한 미네랄 성분을 보충시켜 암예방, 성인병 예방 또는 각종 질환의 예방 및 치료에 도움이 될 수 있는 건강 음료수의 개발이 필요한 것으로 여겨진다.Therefore, it is believed that the supplementation of these mineral components is necessary to develop a healthy beverage that can help prevent cancer, prevent adult diseases, or prevent and treat various diseases.
본 발명자들은 한국 강원도 인근에서 채취한 샘물을 연구한 결과, 필수적인 여러가지 미네랄 뿐만 아니라 특히 게르마늄과 셀레늄이 함유되어 있음을 발견하고, 이 광천수가 건강음료로서 유용함을 발견하여 본 발명을 완성하였다.The present inventors have studied the spring water collected near Gangwon-do, Korea, and found that not only essential minerals but also germanium and selenium are contained, and this mineral water was found to be useful as a health beverage, thus completing the present invention.
본 발명의 목적은 게르마늄 및 셀레늄 등의 각종 미네랄이 함유된 광천수를 이용함으로써 항암효과를 가지며 성인병 예방에도 도움이 되고 인체에 필요한 각종 미네랄 성분을 보충시켜 건강 증진을 도모할 수 있는 건강 음료수를 제공하는 것이다. An object of the present invention is to provide a healthy drink that can improve the health by using mineral water, including various minerals such as germanium and selenium to have anti-cancer effects and to help prevent adult diseases and supplement the various mineral components necessary for the human body will be.
본 발명에 의하면 게르마늄 0.05-0.1ppm, 셀레늄 0.01-0.04ppm, 불소 0.1-1.3ppm, 철 0.005-0.02ppm, 아연 0.005-0.02ppm, 칼슘 20-40ppm, 마그네슘 5-15ppm, 나트륨 0.1-1.5ppm, 칼륨 0.1-1ppm, 실리콘 0.1-1ppm 및 알루미늄 0.01-0.2ppm을 함유하는 광천수 30-70중량%, 한약재 추출물 14-30중량%, 버섯추출물 14-30중량%, 비타민류 1-5중량% 및 기타 첨가제 1-5중량%를 포함하여 이루어진 게르마늄 및 셀레늄 함유 미네랄 건강 음료수가 제공된다.According to the present invention, germanium 0.05-0.1ppm, selenium 0.01-0.04ppm, fluorine 0.1-1.3ppm, iron 0.005-0.02ppm, zinc 0.005-0.02ppm, calcium 20-40ppm, magnesium 5-15ppm, sodium 0.1-1.5ppm, 30-70 wt% mineral water containing 0.1-1ppm potassium, 0.1-1ppm silicon and 0.01-0.2ppm aluminum, 14-30 wt% herbal extract, 14-30 wt% mushroom extract, 1-5 wt% vitamins and others A germanium and selenium containing mineral healthy beverage comprising 1-5% by weight of an additive is provided.
이하 본 발명에 대하여 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에 사용되는 광천수는 강원도 영월군 중동면 직동리에서 취수한 것으로서 화학적인 분석결과 하기 표 1과 같은 성분을 나타낸다.The mineral water used in the present invention is taken from Jikdong-ri, Jungdong-myeon, Yeongwol-gun, Gangwon-do and shows the components as shown in Table 1 below as a result of chemical analysis.
[표 1]TABLE 1
상기 광천수는 유해물질 및 일반 세균, 대장균이 검출되지 않았으며, 특히 다른 음용수와는 달리 게르마늄(0.078ppm) 및 셀레늄(0.027ppm)이 용존되어 있음을 확인할 수 있었다. In the mineral water, no harmful substances, general bacteria, and E. coli were not detected. In particular, unlike other drinking water, germanium (0.078ppm) and selenium (0.027ppm) were dissolved.
게르마늄(Ge)은 물에 용해된 무기물의 형태로는 GeO3 2-이온으로써 존재하며 유기물의 형태로는 단백질 및 식물의 헥산 등에 결합된 형태로 또는 혐기성균에 의한 유기 게르마늄 형태로써 물에 용존되어 존재한다고 볼 수 있다. 무기 이온으로써의 성질은 Sax의 보고에 의하면 게르마늄의 화합물은 납이나 주석과 같이 큰 독성은 없는 것으로 보고된 바 있다. 수용성 합성 게르마늄인 (Ge-CH2-CH2-COOH)2 O3의 구조는 임상결과 다량의 산소를 인체의 미세혈관까지 공급함으로써 순환계 등의 이물질, 노폐물, 독소 등을 산화분해시킴과 동시에 대소변을 통하여 또는 피부로 동반배출시키는 작용을 한다. 특히 항암의 효과도 있는 것으로 알려져 있다. 무기형태인 GeO2는 피부에 접촉함으로써 두통, 관절통, 요통, 좌골신경통, 생리통에 효과가 있는 것으로 알려져 있다.Germanium (Ge) is present as GeO 3 2- ions in the form of minerals dissolved in water and dissolved in water in the form of organic matter bound to proteins and hexane of plants, or in the form of organic germanium by anaerobic bacteria. It can be said to exist. Inorganic ions have been reported by Sax to report that germanium compounds are not as toxic as lead or tin. The structure of (Ge-CH 2 -CH 2 -COOH) 2 O 3 , a water-soluble synthetic germanium, provides a large amount of oxygen to human blood vessels, and oxidizes and decomposes foreign substances such as circulatory system, waste products, and toxins. It acts to be accompanied by or through the skin. It is also known to have anticancer effects. GeO 2 , an inorganic form, is known to be effective in headache, joint pain, back pain, sciatica and menstrual pain by contact with skin.
셀레늄(Se)은 항암 호르몬 및 효소의 활성화 작용을 돕는 물질로 보고되고 있다. 또한 셀레늄은 인체 내에서 주로 간, 신장, 심장, 비장에 분포되어 있는 미량 원소로 체내에서 생성된 과산화수소를 분해하여 세포의 손상을 방지하는 효소의 성분으로서 강력한 항 산화제이다. 세포 내 과산화물의 농도를 낮추어 유리 라디칼의 생성을 방지하는 효소계에 작용하며, 비타민 E는 이미 생성된 유리 라디칼이 더 이상 작용하지 못하게 하므로 셀레늄을 적정량 섭취하면 체내 비타민 E의 요구를 줄일 수 있다. 적혈구의 혈구소가 산화되어 파손되는 것을 예방하고 간 경화증에서 간을 재생시키는 일도 도우며 노화도 지연시키고 수은의 중독도 막아준다.Selenium (Se) has been reported as a substance that helps the activation of anti-cancer hormones and enzymes. In addition, selenium is a trace element distributed mainly in the liver, kidneys, heart, and spleen, and is a powerful antioxidant as a component of an enzyme that decomposes hydrogen peroxide generated in the body and prevents cell damage. By lowering the concentration of peroxide in the cell to prevent the production of free radicals, the enzyme system that acts to prevent the free radicals already produced, the proper amount of selenium can reduce the body's need for vitamin E. It prevents red blood cells from oxidizing and destroying blood cells, helps to regenerate the liver from cirrhosis, delays aging and prevents mercury poisoning.
이와 같이 본 발명에 사용되는 광천수는 몸에은 유익하나 일반적인 샘물에서는 발견되기 어려운 미네랄 성분인 게르마늄 및 셀레늄이 용존되어 있는 것이 특징이라 할 수 있다.As described above, the mineral water used in the present invention is characterized by the fact that germanium and selenium, which are beneficial to the body but are hard to be found in general spring water, are dissolved.
상기 광천수에 함유되는 각종 미네랄의 함량은 전형적으로, 게르마늄 0.05-0.1ppm, 셀레늄 0.01-0.04ppm, 불소 0.1-1.3ppm, 철 0.005-0.02ppm, 아연 0.005-0.02ppm, 칼슘 20-40ppm, 마그네슘 5-15ppm, 나트륨 0.1-1.5ppm, 칼륨 0.1-1ppm, 실리콘 0.1-1ppm 및 알루미늄 0.01-0.2ppm이며, 이러한 광천수는 본 발명의 건강 음료수에 30-70중량%로 포함되는 것이 바람직하다. The content of various minerals contained in the mineral water is typically, germanium 0.05-0.1ppm, selenium 0.01-0.04ppm, fluorine 0.1-1.3ppm, iron 0.005-0.02ppm, zinc 0.005-0.02ppm, calcium 20-40ppm, magnesium 5 -15ppm, sodium 0.1-1.5ppm, potassium 0.1-1ppm, silicon 0.1-1ppm and aluminum 0.01-0.2ppm, the mineral water is preferably included in the health drink of the present invention in 30-70% by weight.
본 발명에 사용되는 한약재 추출물은 이에 한정하는 것은 아니나, 대추, 오미자, 구기자, 감초, 당귀, 황기, 갈근 및 인삼으로 구성되는 그룹으로부터 적어도 하나 선택된 한약재로부터 추출되는 것이 바람직하다. 상기 한약재 추출물은 본 발명의 건강 음료수에 14-30중량%로 포함되는 것이 바람직하다.Herbal extracts used in the present invention is not limited thereto, but is preferably extracted from at least one herbal medicine selected from the group consisting of jujube, Schisandra chinensis, wolfberry, licorice, Angelica, Astragalus, brown root and ginseng. The herbal extract is preferably contained in 14-30% by weight in the healthy beverage of the present invention.
본 발명에 사용되는 한약재의 약용 효능을 살펴보면 다음과 같다.Looking at the medicinal efficacy of the herbal medicine used in the present invention.
대추는 진정, 혈압강하, 배뇨촉진 등의 효능이 있으며 이뇨제, 강장제, 거담제 등으로 쓰이는 것으로 알려져 있다.Jujube is effective in calming, lowering blood pressure and promoting urination, and is known to be used as a diuretic, tonic and expectorant.
오미자는 시잔드린·고미신·시트럴·사과산·시트르산 등의 성분이 들어 있어 심장을 강하게 하고 혈압을 내리며 면역력을 높여 주어 강장제로 사용되며, 폐 기능을 강하게 하고 진해·거담 작용이 있어서 기침이나 갈증 등을 치료하는 데 도움이 되는 것으로 알려져 있다.Schisandrarin, gomisin, citric acid, citric acid, citric acid and other ingredients are used to strengthen the heart, lower blood pressure and boost immunity, which is used as a tonic. It is known to help treat the back.
구기자는 단백질·지방·당질·칼슘·인·철분·베타인·루틴·비타민(A·B1·B2·C) 등이 들어 있어 흡수가 빠르다. 한방에서는 강장제·해열제로 쓰고 간기능 보호 작용이 뛰어나 부작용이 별로 없다. 시력을 좋게 하고 당뇨병 등의 성인병을 예방하며 폐와 신장의 기능을 좋게 하고, 들기름과 섞어 숙성해 두었다가 머리에 바르면 흰머리가 생기는 것을 막아 주고 화상에도 효과가 있는 것으로 알려져 있다.Goji berries contain protein, fat, sugar, calcium, phosphorus, iron, betaine, rutin, and vitamins (A · B 1 · B 2 · C). In oriental medicine, it is used as a tonic and antipyretic. It is said to improve vision and prevent adult diseases such as diabetes, improve the function of lungs and kidneys, and mix it with perilla oil and apply it to the hair to prevent the formation of gray hair and to burn.
감초는 모든 약의 독을 풀어 중화 및 완화시키는 작용을 하므로 한방 처방에서는 필수불가결한 묘약이다. 또한 감초는 부신피질호르몬처럼 조정작용도 있어 급박한 증상을 푸는 것으로 근육의 긴장으로 인한 동통이나 신경의 긴장을 풀어주는 작용을 하며, Glycyrrhizin이 항알러지 작용을 하며, 위궤양, 십이지장궤양에도 효과가 크다. 또한, 탈콜레스테롤 작용이 있어 동맥경화를 예방하고, 유독물질을 해독하는 작용을 하므로 간장의 기능을 강화시킨다. 이 밖에 늑막염과 폐결핵에도 뚜렷한 치료 효과를 보였고, 뇌하수체전엽기능부전증, 에디슨병, 유행성 간염, 기관지천식, 피부염(두드러기, 습진, 여드름, 주근깨 등), 학질, 동상, 손발이 튼데 등 여러 질병에 뚜렷한 치료 효과를 보았다는 보고가 있다.Licorice is a potion that is indispensable in herbal medicine because it acts to detoxify and alleviate all medicines. In addition, licorice has an adjustment effect like corticosteroids, which helps to relieve urgent symptoms and to relieve pain and nerve tension caused by muscle tension. Glycyrrhizin has an anti-allergic effect, and is also effective in gastric ulcer and duodenal ulcer. . In addition, there is a de-cholesterol action to prevent atherosclerosis, and acts to detoxify toxic substances, thereby enhancing the function of the liver. In addition, pleurisy and pulmonary tuberculosis have been shown to have a distinct therapeutic effect, and pituitary inferior dysfunction, Edison's disease, epidemic hepatitis, bronchial asthma, dermatitis (such as urticaria, eczema, acne, freckles), scholasticism, frostbite, and limbs. There have been reports of therapeutic effects.
당귀는 산형과에 속하는 숙근초(宿根草)로 그 뿌리가 약재로 쓰이는데, 방향성 정유와 설탕·비타민 E 등이 함유되어 있다. 월경을 조절하고 월경통을 제거해 주며 빈혈에도 유효하다. 만성화농증에 사용하면 순환을 개선시키고 체내의 저항력을 증강시키며, 변비에 효과가 있는 것으로 알려져 있다.Angelica is a medicinal herb belonging to the mountain family, and its root is used as a medicinal herb. It contains aromatic essential oils and sugar and vitamin E. Regulates menstruation, eliminates dysmenorrhea and is also effective for anemia. When used for chronic purulentemia, it is known to improve circulation, increase body resistance, and constipation.
황기는 강장·지한(止汗)·이뇨(利尿)·소종(消腫) 등의 효능이 있어 신체허약·피로권태·기혈허탈(氣血虛脫)·탈항(脫肛)·자궁탈·내장하수·식은땀·말초신경 등의 치료에 유용한 것으로 알려져 있다. Astragalus is effective in tonic, cold, diuretic, and small-species, so it has physical weakness, fatigue boredom, deprivation of blood, deprivation, uterine degeneration, internal sewage, and It is known to be useful for the treatment of sweat and peripheral nerves.
갈근은 발한 ·해열 ·완하제(緩下劑)로서 고열 ·두통 ·고혈압 ·심부전 ·설사 ·어깨가 결릴 때 등에 유용하며, 특히 갈근탕은 감기약으로서 유용하다. Brown root is a sweating, antipyretic, laxative, and is useful for high fever, headache, high blood pressure, heart failure, diarrhea, and shoulder stiffness.
인삼은 원기를 크게 보하고 폐를 튼튼하게 하며, 비장(脾臟)을 좋게하고, 심장을 편안하게 해준다고 했으며, 신농본초경(神農本草徑)에는 인삼은 오장(五臟) 즉 간장, 심장, 폐장, 신장, 비장의 양기(陽氣)를 돋구어 주는 주약으로 사용하고, 정신을 안정시키고, 오부로 진입하는 병사(病邪)를 제거하여 주며, 눈을 밝게 하고 지혜롭게 하고, 오래 복용하면 몸이 가벼워지고 장수한다고 하였으며, 특히 사포닌 성분이 들어있어 항암효과가 우수한 것으로 알려져 있다.Ginseng is said to be a great source of energy, to strengthen the lungs, to improve the spleen, and to make the heart comfortable. Ginseng is the five intestines of the soy sauce, heart, lung, kidney, and kidney. It is used as a medicine to nourish the spleen's yang, stabilizes the mind, removes the soldiers who enter the fives, brightens the eyes and makes them wise, and when taken for a long time, makes the body lighter and longer life. In particular, it contains saponin, which is known to have excellent anticancer effects.
본 발명에 사용되는 버섯 추출물은 이에 한정하는 것은 아니나, 동충하초, 상황버섯, 영지버섯, 송이버섯, 표고버섯, 아가리쿠스, 운지버섯 및 복령으로 구성되는 그룹으로부터 적어도 하나 선택된 버섯으로부터 추출되는 것이 바람직하다. 상기 버섯 추출물은 본 발명의 건강 음료수에 14-30중량%로 포함되는 것이 바람직하다.Mushroom extract used in the present invention is not limited thereto, but is preferably extracted from at least one mushroom selected from the group consisting of Cordyceps sinensis, situation mushroom, Ganoderma lucidum mushroom, Matsutake mushroom, shiitake mushroom, Agaricus, cloud finger mushroom and Bokryeong. The mushroom extract is preferably included in 14-30% by weight in the healthy beverage of the present invention.
본 발명에 사용되는 버섯의 약용 효능을 살펴보면 다음과 같다.Looking at the medicinal efficacy of the mushrooms used in the present invention.
동충하초는 폐결핵, 노인쇠약성만성결핵, 빈혈, 허약, 유정, 양위(임포텐츠)등에 효능이 있는 것으로 알려져 있다.Cordyceps sinensis is known to be effective in pulmonary tuberculosis, geriatric chronic chronic tuberculosis, anemia, weakness, oil well, and stomach (impotents).
상황버섯은 소화기 계통의 암인 위암, 식도암, 십이지장암, 결장암, 직장암,을 비롯한 간암의 절제 수술후 화학요법을 병행할 때 면역기능을 항진시키며, 자궁출혈 및 대하, 월경불순, 장출혈, 오장 및 위장 기능을 활성화 시키고 해독작용을 가지며 또한 항암성이 있는 것으로 알려져 있다. Situation mushrooms increase immune function when chemotherapy is performed after resection of liver cancer including gastric cancer, esophageal cancer, duodenal cancer, colon cancer, rectal cancer, and other cancers of the digestive system. It is known to activate and have detoxification and anticancer activity.
영지버섯은 몸이 허한데, 기허증, 혈허증, 신경쇠약환자의 불면증, 간염, 고혈압, 동맥경화증, 만성기관지염, 협심증 등에 효능이 있으며 또한 빈혈, 뇌진탕후유증, 편두통, 류마티스성관절염, 콩팥염, 갑상선기능항진등에도 일정한 효과가 있는 것으로 알려져 있다. Ganoderma lucidum is very vulnerable, but it is effective in insomnia, hepatitis, hypertension, arteriosclerosis, chronic bronchitis, angina pectoris, anemia, concussion sequelae, migraine, rheumatoid arthritis, kidney disease, thyroid gland. It is known to have a certain effect on hyperfunction.
송이버섯은 위암이나 직장암 같은 질병의 발생을 억제하는 크리스틴이라는 항암 성분이 들어있는 것으로 알려져 일본에서는 항암 식품으로 알려져 있다. Matsutake mushroom is known to contain an anti-cancer ingredient called Christine, which suppresses the occurrence of diseases such as stomach and rectal cancer, and is known as an anti-cancer food in Japan.
표고버섯은 항암 및 항종양작용, 항바이러스 작용, 혈압강하 및 혈중 콜레스테롤 강하작용, 항바이러스 물질인 인터페론의 생성 촉진작용, 당뇨병, 비만증, 동맥경화, 고혈압 개선작용을 나타내며, 장기를 튼튼하게 하고, 풍파혈을 다스리고 또한 에르고스테롤이란 성분이 들어 있어 햇볕의 자외선에 쬐면 모두 비타민 D2로 변하기 때문에 표고버섯은 구루병을 예방하고 빈혈을 치료하는 기능이 있다.Shiitake mushroom has anti-cancer and anti-tumor action, antiviral action, lowering blood pressure and lowering blood cholesterol, promoting the production of interferon, an antiviral substance, diabetes, obesity, arteriosclerosis, hypertension, and strengthening organs, Shigo mushrooms have a function to prevent wind rash and to treat anemia because it contains the ingredient ergosterol and turns into vitamin D 2 when exposed to ultraviolet rays in the sun.
아가리쿠스는 흰들버섯 또는 신령버섯이라고 불리우는데 이 버섯은 브라질의 피에다데라고하는 산간지역에 자생하던 식물인데 이 지방사람들은 예로부터 이 버섯을 복용하여 무병장수 하였으며 여러 학자들의 연구결과 그 약효와 효능이 세상에 알려지게 되었다. 특히 레이건 전 미국대통령이 암치료를 위해 이 버섯을 복용했다고 한다. 항종양 활성, 면역증강작용, 항염증작용, 혈당강화작용, 강심, 혈압강하, 콜레스테롤 저하, 치매개선효과, 비만억제효과, 식물섬유효과, 골다공증 예방효과 등에 효과가 있다. Agaricus is called a white mushroom or a psychedelic mushroom, which is a plant native to a mountainous region called Piedade in Brazil. The locals have long been disease-free by taking this mushroom. It became known to this world. Former US President Reagan took the mushroom for cancer treatment. Anti-tumor activity, immune enhancing, anti-inflammatory, blood sugar strengthening, cardiac, blood pressure, cholesterol lowering, dementia improvement, obesity inhibitory effect, plant fiber effect, osteoporosis prevention effect.
운지버섯은 항암효과와 간세포 손상을 억제시키는 작용이 있어 만성 간질환 환자에게 효과가 있는 것으로 알려져 있다. 또한 상황버섯과 영지버섯에 못지않는 항암성분을 가지고 있는 것으로 알려져 있다.Cloud finger mushroom is known to be effective in patients with chronic liver disease because it has an anticancer effect and inhibits liver cell damage. It is also known to have anticancer ingredients comparable to situation mushrooms and ganoderma lucidum.
복령은 폐경, 비경, 심경, 방광경에 작용한다. 소변을 잘 보게 하고 비를 보하며 담을 삭이고 정신을 안정시킨다. 약리실험에서 이뇨작용, 혈당량 낮춤작용, 진정작용 등이 밝혀졌다. 복령의 다당류는 면역 부활작용, 항암작용을 나타낸다. 비허로 붓는데, 복수, 담음병, 설사, 소변이 잘 안 나오는 데, 가슴이 두근거리는 데, 불면증, 건망증, 만성 소화기성 질병 등에 효능이 있는 것으로 알려져 있다.Bokryeong works on menopause, parenteral, heart, and bladder. Pee well, rain, cleanse the wall, and calm the mind. Pharmacological experiments revealed diuretic, hypoglycemic and sedative effects. The polysaccharides of Bokyeong exhibit immune resiliency and anticancer activity. Unpleasant swelling, revenge, diarrhea, diarrhea, urine does not come out well, chest palpitations, insomnia, forgetfulness, chronic digestive diseases are known to be effective.
본 발명에 사용되는 비타민류의 종류는 이에 한정하는 것은 아니나, 비타민 A, B1, B2, B6, B12, B13, C, D2, D 3, D4, D5, D6, D7 및 E로 구성되는 그룹으로부터 적어도 하나 선택된 비타민이 바람직하다. 상기 비타민은 본 발명의 건강 음료수에 1-5중량%로 포함되는 것이 바람직하다.The kind of vitamins used in the present invention is not limited thereto, but vitamins A, B 1 , B 2 , B 6 , B 12 , B 13 , C, D 2 , D 3 , D 4 , D 5 , D 6 Preferred is a vitamin at least one selected from the group consisting of D 7 and E. The vitamin is preferably contained in 1-5% by weight of the healthy beverage of the present invention.
또한 기타 첨가제로 설탕, 소금, 벌꿀, 구연산, 아미노산, 감미제 또는 향료 등이 첨가될 수 있다. 이러한 기타 첨가제는 본 발명의 건강 음료수에 1-5중량%로 포함되는 것이 바람직하다.Other additives may also include sugar, salt, honey, citric acid, amino acids, sweeteners or flavorings. Such other additives are preferably included in the health beverage of the present invention in 1-5% by weight.
나아가 본 발명의 건강 음료수는 과일 추출물을 더욱 포함할 수 있다. 본 발명에 사용되는 과일 추출물은 매실, 오렌지, 파인애플, 석류, 자몽, 망고, 바나나, 체리, 아보카도, 키위, 사과, 배, 복숭아 및 포도로 구성되는 그룹으로부터 적어도 하나 선택될 수 있다. 상기 과일 추출물의 첨가량은 이에 한정하는 것은 아니나, 건강 음료수 100중량부 기준으로 1-10중량부로 첨가하는 것이 바람직하다.Furthermore, the healthy beverage of the present invention may further comprise a fruit extract. The fruit extract used in the present invention may be at least one selected from the group consisting of plum, orange, pineapple, pomegranate, grapefruit, mango, banana, cherry, avocado, kiwi, apple, pear, peach and grape. The amount of the fruit extract is not limited thereto, but is preferably added in an amount of 1-10 parts by weight based on 100 parts by weight of the healthy beverage.
이하 실시예를 통하여 본 발명을 보다 상세히 설명한다.Hereinafter, the present invention will be described in more detail with reference to the following examples.
실시예 1Example 1
우리나라에서 음용되는 생수, 수돗물과 외국에서 수입된 애비앙 생수 및 영월군 직동리에서 채취한 광천수를 시료로 하여 수질분석을 행하였다. Water quality analysis was performed using fresh water, tap water, drinking water imported from Korea, and mineral water taken from Jikdong-ri, Yeongwol-gun.
수질분석은 다음과 같은 기기 및 방법을 통해 수행하였다.Water quality analysis was performed using the following instruments and methods.
시료 분석 기기Sample analysis instrument
(1) ICAP(Inductively Coupling Argon Plasma): Thermal-jarrell ash ENVIRO II Polyscan 61E, 미국(1) Inductively Coupling Argon Plasma (ICAP): Thermal-jarrell ash ENVIRO II Polyscan 61E, USA
(2) NMR Spectrometer: FT-NMR 500MHz. Model UI500, 일본(2) NMR Spectrometer: FT-NMR 500MHz. Model UI500, Japan
(3) Ion Chromatography: DIONX 45001, 미국(3) Ion Chromatography: DIONX 45001, USA
(4) Spectrophotometer: Metertek SP-830, 미국(4) Spectrophotometer: Metertek SP-830, USA
(5) XRD(X-Ray Diffraction Detector): Rikaku, 일본(5) X-Ray Diffraction Detector (XRD): Rikaku, Japan
(6) FT-IR spectrophotometer: MIDAC, Model 2400C, 미국(6) FT-IR spectrophotometer: MIDAC, Model 2400C, USA
(7) Electic Conductivity: Isteck Model, 455C:SIR NO. 9811013C, 한국(7) Electic Conductivity: Isteck Model, 455C: SIR NO. 9811013C, South Korea
(8) pH and ORP(Oxidation and Reduction Potential) meter: Isteck Model, 750P SIRNO. P811080P, 한국(8) pH and Oxidation and Reduction Potential (ORP) meter: Isteck Model, 750P SIRNO. P811080P, Korea
(9) DO-meter: AMEL NO. 97235(9) DO-meter: AMEL NO. 97235
(10) Vacuum freezer dryer: VF0005-5085, 한국(10) Vacuum freezer dryer: VF0005-5085, Korea
분석 방법Analytical Method
(1) ICAP 분석(1) ICAP analysis
플라즈마 가스는 아르곤을 사용하였고 분석방법은 폴리모드 모노 팩터를 택하여 분석하였다. 특히 게르마늄의 표준물질은 Ge를 0.2N-KOH에 용해된 것을 사용하였다.Argon was used as the plasma gas, and the analysis method was selected using a polymode mono factor. Particularly, the standard material of germanium was one in which Ge was dissolved in 0.2N-KOH.
(2) 이온 크로마토그래피 분석(2) ion chromatography analysis
각 물질마다 표준물질은 특급시약을 사용하였다.For each substance, standard reagents were used.
(3) X-선 회절 분석(3) X-ray diffraction analysis
XRD의 분석 조건은 하기 표 2와 같다.XRD analysis conditions are shown in Table 2 below.
[표 2]TABLE 2
(4) 분광 광도 분석(4) spectrophotometric analysis
REN-ZAC의 검량선법을 이용하여 게르마늄을 분석하고 표준물질과 비교 분석하였다.Germanium was analyzed using the calibration curve method of REN-ZAC and compared with the standard material.
(5) 전기 전도도, pH, ORP 및 DO의 측정(5) Measurement of electrical conductivity, pH, ORP and DO
실험실의 실온을 25℃를 기준으로 하여 전기 전도도를 ㎲/㎝ 단위로 측정하였으며 3차 증류된 초순수를 기준으로 측정하였다. 또한 ORP, pH 및 DO도 상기 기준과 동일한 방법으로 측정하였다.The electrical conductivity of the laboratory was measured based on 25 ° C. based on the temperature of 25 ° C. and measured based on the third distilled ultrapure water. In addition, ORP, pH and DO were also measured in the same manner as the above standard.
(6) 초순수의 초냉각 얼음상태의 ORP 측정(6) ORP measurement in ultra cool ice state of ultrapure water
진공냉동건조기를 이용하여 초순수를 -40℃에서 냉각시킨 얼음에 홀을 내고 그 주위의 초순수의 pH 및 ORP를 측정하여 6각수 중의 안정된 에너지 상태, 즉 환원전위(reduced potential)를 측정하여 6각 구조 형태의 클러스터 상태를 기준으로 하고 다른 시료와 비교 검토하였다.Hexagonal structure is made by measuring the stable energy state in hexagonal water, namely reduced potential, by measuring the pH and ORP of the ultrapure water around it by using the vacuum freeze dryer in the ice cooled at -40 ℃. Based on cluster status of morphology and compared with other samples.
(7) 삼투압(osmotic pressure)의 측정(7) measurement of osmotic pressure
인체에 가장 잘 흡수될 수 있는 물을 찾기 위하여 물의 온도를 인체의 온도 36℃로 유지하고 측정기구는 Zimam 및 Myerson의 실험 장치에 근거하여 van't hoff 관을 제작하여 사용하였고 용액은 묽은 아미노산을 함유한 용액을 사용하였다. 멤브레인 필터(whatman의 공극 크기 0.2㎛, 직경 47mm)를 이용하여 각 시료의 삼투압을 측정하였다. 1748년 Abbe Nollet의 삼투압현상의 보고 및 1877년 van't hoff 및 pfeffer의 설탕용액에 대한 삼투압이 측정 결과의 근사식 πV=RT에 의한 원리를 이용하였다.In order to find the water that can be absorbed best by the human body, the temperature of the water was maintained at 36 ° C of the human body, and the measuring instrument was made by using van't hoff tubes based on Zimam and Myerson's experimental devices. The solution contained was used. The osmotic pressure of each sample was measured using a membrane filter (whatman's pore size of 0.2 mu m, diameter 47 mm). The report of the osmotic pressure of Abbe Nollet in 1748 and the osmotic pressure of sugar solution of van't hoff and pfeffer in 1877 were used as an approximation of the measurement result πV = RT.
(8) 원적외선(far infrared) 분석방법(8) Far infrared analysis method
분석 시료를 진공냉동건조기로 건조한 후 37℃에서 파장 5-20㎛사이의 방사율 및 방사에너지를 측정하였다.After drying the analytical sample in a vacuum freeze dryer, the emissivity and the radiation energy between 5-20 μm at 37 ° C. were measured.
수질분석 결과를 하기 표 3에 나타내었다.Water quality analysis results are shown in Table 3 below.
[표 3]TABLE 3
(단위:ppm) (Unit: ppm)
표 3 계속Table 3 continued
*ND: Non Detection(무검출)* ND: Non Detection
평가evaluation
각각의 음용수들의 물리화학적 특성에 대한 검토결과 다음과 같은 결론을 얻을 수 있었다.As a result of examining the physicochemical characteristics of each drinking water, the following conclusions were obtained.
측정된 음용수에서는 모두 유해물질 및 일반 세균, 대장균이 검출되지 않았으며, 특히 직동리 샘물은 다른 음용수와는 달리 게르마늄(0.078ppm), 세레늄(0.027ppm) 및 실리콘(0.68ppm)이 미량 용존되어 있음을 확인할 수 있었다. In the measured drinking water, no harmful substances, common bacteria and E. coli were detected. I could confirm it.
인체에 유익한 pH는 약 7.4 정도인 것과 관련하여 에비앙 생수 및 시판생수는 각각 7.54 및 7.69로 약간 높은데 비하여 직동리 샘물은 7.4로 가장 근접하여 적합하였다. The pH of the human body was about 7.4, while the Evian bottled water and commercial bottled water were slightly higher at 7.54 and 7.69, respectively.
ORP 분석결과 애비앙과 직동리 샘물이 초냉각 얼음 주변의 ORP값에 근접하였으며, 이 결과로부터 물 군집(Cluster)중 육각수 생성비율이 약 56%정도인 것으로 나타났다.As a result of ORP analysis, Abian and Jikdong-ri springs were close to the ORP values around the supercooled ice, and the results showed that the ratio of hexagonal water generation in the water cluster was about 56%.
삼투압 측정결과 직동리 샘물이 17.5mmH2O로 가장 높게 나타났으며, 그 다음으로 애비앙 샘물이 16.0mmH2O로 높게 나타났다. 따라서 세포주변의 물 전달 기능은 직동리 샘물이 가장 우수한 것으로 판단되었다.Osmotic pressure was found to be the highest at 17.5mmH 2 O, followed by Abian spring at 16.0mmH 2 O. Therefore, the water transfer function around the cell was judged to be the best in spring water.
NMR 스펙트럼 분석결과 half-width가 직동리 샘물이 가장 넓고 그 다음으로 애비앙 생수가 높게 나타났다. 따라서 물의 안정도는 직동리 샘물이 가장 우수한 것으로 판단되었다.NMR spectral analysis showed that half-width was the largest in springs and the highest in Avian water. Therefore, the stability of water was judged to be the best in Jikdong-ri spring.
직동리 샘물의 증발잔유물의 원적외선 분석결과 Black-body에 대한 비율이 90.6%로써 방사에너지는 3.49×102W/㎡이며, 진동수는 1.359×1013-5.460×1013 Hz 인 파동을 갖는 것으로 나타났다.Far-infrared analysis of the evaporated residue of the Jikdong-ri spring showed 90.6% of the black-body ratio, and the radiation energy was 3.49 × 10 2 W / ㎡ and the frequency was 1.359 × 10 13 -5.460 × 10 13 Hz.
실시예 2Example 2
영월군 직동리에서 채취한 광천수(직동리 샘물)를 이용하여 하기 표 4에 나타난 바와 같은 조성으로 건강 음료수를 제조하였다. Using a mineral water (jikdongri spring water) collected from Jikdong-ri Yeongwol-gun was prepared a healthy beverage with the composition as shown in Table 4.
건강 음료수 제조에 사용된 한약재 추출물과 버섯추출물의 추출은 다음과 같은 방법으로 이루어졌다. 건조된 재료(한약재 및 버섯) 100g을 1리터 추출용 플라스크에 넣고 환류냉각기를 부착하여 증류수 500ml을 붓고 70℃에서 6시간 추출하였다. 그 다음 추출액을 모아 5℃에서 5시간 냉각 침전시켜서 상등액을 취하고 그 찌꺼기를 10㎛필터로 여과하였다. 그 여과액을 모아 회전 진공증발기로 70℃이하로 감암농축하여 고형분이 약 25˚Bx가 되도록 하였다.Extraction of herbal extracts and mushroom extracts used in the manufacture of healthy beverages was made by the following method. 100 g of the dried material (medicinal herbs and mushrooms) was placed in a 1-liter extraction flask, a reflux cooler was attached, 500 ml of distilled water was poured, and extracted at 70 ° C. for 6 hours. Then, the extract was collected, cooled and precipitated at 5 ° C. for 5 hours to obtain a supernatant, and the residue was filtered through a 10 μm filter. The filtrate was collected and concentrated to 70 ° C. or less with a rotary vacuum evaporator so that the solid content was about 25 ° Bx.
[표 4] TABLE 4
단위: 중량% Unit: weight%
상기 제조된 건강 음료수들에 대한 관능검사를 실시한 결과를 하기 표 5에 나타내었다. 관능검사는 20세 초반의 담배를 피지 않는 여성을 무작위로 20명을 패널요원으로 선정하여 Sensory Score Sheet법으로 행하였다. 관능검사에서 색깔, 향, 맛 및 종합적 기호도에 대한 평가는 1-5점으로 하였으며 그 결과는 표 5에 나타내었다.The results of conducting the sensory test on the prepared healthy drinks are shown in Table 5 below. Sensory score sheet method was used to select 20 females who did not smoke in the early 20s. In sensory evaluation, the evaluation of color, aroma, taste, and overall acceptability was 1-5 points, and the results are shown in Table 5.
[표 5]TABLE 5
*점수: 아주나쁨; 1점, 나쁨; 2점, 보통;3점, 좋음; 4점, 아주 좋음; 5점* Score: very poor; 1 point, bad; 2 points, moderate; 3 points, good; 4 points, Very good; 5 points
본 발명의 건강 음료수는 인체에 필요한 게르마늄과 셀레늄을 포함한 각종 미네랄 성분을 보충시켜줄 수 있으며 또한 추가적으로 몸에 유익한 한약재추출물, 버섯추출물, 비타민 등이 함유되어 있어 암예방 및 성인병 예방에도 도움이 되는 등 건강 증진 효과를 기대할 수 있다. The health drink of the present invention can supplement various mineral components including germanium and selenium necessary for the human body, and also contain beneficial herbal extracts, mushroom extracts, vitamins, etc., which are beneficial to the body, and thus help prevent cancer and prevent adult diseases. You can expect a boost.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040031621A KR20050106631A (en) | 2004-05-06 | 2004-05-06 | Mineral health drink containing germanium and selenium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040031621A KR20050106631A (en) | 2004-05-06 | 2004-05-06 | Mineral health drink containing germanium and selenium |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20050106631A true KR20050106631A (en) | 2005-11-11 |
Family
ID=37283363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040031621A KR20050106631A (en) | 2004-05-06 | 2004-05-06 | Mineral health drink containing germanium and selenium |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20050106631A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100843776B1 (en) * | 2006-12-01 | 2008-07-03 | 박민경 | The composites and processing method of shiitake mushroom extract improving functional constipation |
KR100863893B1 (en) * | 2007-01-02 | 2008-10-17 | 서희동 | A method to produce drinking water from a mineral water and deep-ocean water |
KR100863896B1 (en) * | 2006-12-26 | 2008-10-17 | 서희동 | A production method of drinking water from a mineral water |
KR100871805B1 (en) * | 2007-01-13 | 2008-12-03 | 서희동 | A method to produce drinking water from a mineral water |
KR101011038B1 (en) * | 2008-03-31 | 2011-01-26 | 풍기인삼협동조합 | Red Ginseng Extracts and Drink Containing the Same |
KR101299403B1 (en) * | 2012-12-17 | 2013-08-22 | 조인선 | Preparation method for ion beverage using salt water |
KR101382199B1 (en) * | 2013-12-23 | 2014-04-07 | 주식회사 해인인터내셔널 | Method for production of far-infrared ray radiating liquid composition |
KR101539756B1 (en) * | 2014-11-03 | 2015-07-28 | 성용재 | packing method of natural water and natural water using the same |
CN108157714A (en) * | 2017-12-26 | 2018-06-15 | 广西巴马中脉寿乡矿泉水有限公司 | A kind of ganoderma lucidum mineral water |
-
2004
- 2004-05-06 KR KR1020040031621A patent/KR20050106631A/en not_active Application Discontinuation
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100843776B1 (en) * | 2006-12-01 | 2008-07-03 | 박민경 | The composites and processing method of shiitake mushroom extract improving functional constipation |
KR100863896B1 (en) * | 2006-12-26 | 2008-10-17 | 서희동 | A production method of drinking water from a mineral water |
KR100863893B1 (en) * | 2007-01-02 | 2008-10-17 | 서희동 | A method to produce drinking water from a mineral water and deep-ocean water |
KR100871805B1 (en) * | 2007-01-13 | 2008-12-03 | 서희동 | A method to produce drinking water from a mineral water |
KR101011038B1 (en) * | 2008-03-31 | 2011-01-26 | 풍기인삼협동조합 | Red Ginseng Extracts and Drink Containing the Same |
KR101299403B1 (en) * | 2012-12-17 | 2013-08-22 | 조인선 | Preparation method for ion beverage using salt water |
KR101382199B1 (en) * | 2013-12-23 | 2014-04-07 | 주식회사 해인인터내셔널 | Method for production of far-infrared ray radiating liquid composition |
KR101539756B1 (en) * | 2014-11-03 | 2015-07-28 | 성용재 | packing method of natural water and natural water using the same |
CN108157714A (en) * | 2017-12-26 | 2018-06-15 | 广西巴马中脉寿乡矿泉水有限公司 | A kind of ganoderma lucidum mineral water |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6579544B1 (en) | Method for supplementing the diet | |
US10842839B2 (en) | Natural formulation for treating hangover | |
US20060147600A1 (en) | 'Maca Blast' energy drink | |
CA2409807A1 (en) | Recovery drink formula and method | |
WO2008014674A1 (en) | A nutritional and health-care edible potassium salt with wide purpose | |
US20090246323A1 (en) | Isotonic Energy Drink | |
KR20050106631A (en) | Mineral health drink containing germanium and selenium | |
KR20110013685A (en) | A functional beverage comprising deep sea water, extract of fermented black ginger and extract of jujubae fructus as main ingredients | |
KR20100112215A (en) | A functional beverage comprising deep sea water, extract of red ginseng, extract of jujubae fructus, extract of cnidii rhizoma, extract of glycyrrhizae radix and extract of lycii fructus as main ingredients | |
CN100415107C (en) | Indian herbal soft drink | |
CN101380128A (en) | Zhukui multifunctional health care beverage and production method thereof | |
KR20100114974A (en) | A functional beverage comprising deep sea water, extract of black garlic, extract of jujubae fructus and organic acid | |
Rakhimov et al. | Resonance therapy. Ceramic materials and methods of their application in medicine | |
KR101119645B1 (en) | A functional beverage composition comprising deep sea water, taurine, vitamins, royal jelly and propolis as main ingredients | |
KR100482999B1 (en) | Health Beverage composition using the concentrate of Deep Ocean Water | |
RU2458538C1 (en) | Dietary, prophylactic and functional food product with probiotic b for sport alimentation | |
KR100336650B1 (en) | The composites of raw-type tea with the function of activating the brain and promoting the growth | |
KR20040091418A (en) | Method for manufacturing melanian snail extract and functional food having the extract | |
CN107788515A (en) | A kind of desertliving cistanche nutritive composition and preparation method thereof | |
KR20100117691A (en) | Health salt containing concentrated plum juice and it's manufacturing method | |
KR20100055026A (en) | Manufacturing method of foods using chinese medicine and red ginseng and product thereof | |
KR102356727B1 (en) | Method of producing fuctional eggs with enhanced antioxidant | |
CN110050911A (en) | Five-cereal health-care dew | |
RU2694582C1 (en) | Functional beverage | |
KR20150048332A (en) | Manufacturing method edible salt of liquid and solid with unripeapricot conentration and organic mineral mixture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |